Adeniyi Ade A, Brindley Giles S, Pryor John P, Ralph David J
Institute of Urology and Nephrology, London W1P 7EY, UK.
Asian J Androl. 2007 May;9(3):403-7. doi: 10.1111/J.1745-7262.2007.00276.x.
To study the effect of yohimbine in the treatment of men with orgasmic dysfunction.
A 20-mg dose of yohimbine was first given to 29 men with orgasmic dysfunction of different aetiology in the clinic. Patients were then allowed to increase the dose at home (titration) under more favourable circumstances. The outcome and side effects were subsequently assessed.
The patients were classified into three groups of orgasmic dysfunction: primary complete (13), primary incomplete (8) and secondary (8). Nocturnal emissions were present in 75%, 40% and 50% of patients in the above groups, respectively (overall average 62%). The men presented because of fertility problems (52%) or because they wanted to experience the pleasure of orgasm (48%). Of the 29 patients who completed the treatment, 16 managed to reach orgasm and were able to ejaculate either during masturbation or sexual intercourse. A further three achieved orgasm, but only with the additional stimulation of a vibrator. A history of preceding nocturnal emissions was present in 69% of the men in whom orgasm was induced but only 50% who failed treatment. Of the patients, two have subsequently fathered children (one set of twins) and another 3 men were also cured. Side effects were not sufficient to cause the men to cease treatment.
Yohimbine is a useful treatment option in orgasmic dysfunction.
研究育亨宾治疗男性性高潮功能障碍的效果。
首先对29名临床诊断为不同病因性高潮功能障碍的男性给予20毫克剂量的育亨宾。随后让患者在更有利的环境下在家中增加剂量(滴定)。随后评估结果和副作用。
患者被分为三组性高潮功能障碍:原发性完全性(13例)、原发性不完全性(8例)和继发性(8例)。上述三组患者中分别有75%、40%和50%出现夜间遗精(总体平均为62%)。这些男性就诊的原因是生育问题(52%)或他们想体验性高潮的快感(48%)。在完成治疗的29名患者中,16名成功达到性高潮,并能够在自慰或性交时射精。另外3名达到了性高潮,但仅在使用振动器额外刺激的情况下。在诱导出性高潮的男性中,69%有夜间遗精史,而治疗失败的男性中这一比例仅为50%。在这些患者中,有两名随后生育了子女(一对双胞胎),另外3名男性也被治愈。副作用不足以导致男性停止治疗。
育亨宾是治疗性高潮功能障碍的一种有效选择。